Buscar

Mostrando ítems 1-10 de 318

Cutaneous Manifestations of Human and Murine Leishmaniasis

Scorza, Breanna M; Carvalho Filho, Edgar Marcelino; Wilson, Mary E (MDPI, 2017)

Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages

Reis, Mitermayer Galvão dos; Roters, S B; Barral Netto, Manoel (Elsevier, 2016)

Activity of antimalarial drugs in vitro and in a murine model of cutaneous leishmaniasis

Rocha, Vin??cius Pinto Costa; Nonato, Fabiana Regina; Guimar??es, Elisalva Teixeira; Freitas, Luiz Ant??nio Rodrigues de; Soares, Milena Botelho Pereira (2013)

Amiodarone and Miltefosine Act Synergistically against Leishmania mexicana and Can Induce Parasitological Cure in a Murine Model of Cutaneous Leishmaniasis

Serrano-Martín, X; Payares, G; De Lucca, M; Martinez, J; Mendoza-León, Alexis; Benaím, Gustavo (ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013)

Cutaneous Manifestations of Human and Murine Leishmaniasis

Scorza, Breanna M; Carvalho Filho, Edgar Marcelino; Wilson, Mary E (MDPI, 2017)

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Universidade Federal do Rio de Janeiro (UFRJ); Universidade Estadual Paulista (Unesp) (Elsevier B.V., 2002-11-22)

The FML antigen of Leishmania donovani, in combination with either Riedel de Haen (R), QuilA, QS21 saponins, IL12 or BCG, was used in vaccination of an outbred murine model against visceral leishmaniasis (VL). Significant ...

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Universidade Federal do Rio de Janeiro (UFRJ); Universidade Estadual Paulista (Unesp) (Elsevier B.V., 2002-11-22)

Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo

Linares, E; Augusto, O; Barao, SC; Giorgio, S (Amer Soc ParasitologistsLawrenceEUA, 2000)

Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis

Barral Netto, Manoel; Cardoso, Silvia Andrade; Barral, Aldina Maria Prado (Elsevier, 2018)

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Santos, W. R.; de Lima, VMF; de Souza, E. P.; Bernardo, R. R.; Palatnik, M.; de Sousa, CBP (Elsevier B.V., 2014)

1
2
3
4
. . .
32

Buscar

Filtros

Cutaneous Manifestations of Human and Murine Leishmaniasis

Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages

Activity of antimalarial drugs in vitro and in a murine model of cutaneous leishmaniasis

Amiodarone and Miltefosine Act Synergistically against Leishmania mexicana and Can Induce Parasitological Cure in a Murine Model of Cutaneous Leishmaniasis

Cutaneous Manifestations of Human and Murine Leishmaniasis

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis

Leishmania amazonensis infection does not inhibit systemic nitric oxide levels elicited by lipopolysaccharide in vivo

Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis

Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis